Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
The Journal of Cell Biology
|
November 1, 1988
Structural and immunological characterization of the myosin-like 110-kD subunit of the intestinal microvillar 110K-calmodulin complex: evidence for discrete myosin head and calmodulin-binding domains
J M Carboni, K A Conzelman, R A Adams, et al.
The American Journal of Pathology
|
December 1, 1987
Characterization of intestinal brush border cytoskeletal proteins of normal and neoplastic human epithelial cells. A comparison with the avian brush border
J M Carboni, C L Howe, A B West, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 8, 1999
Use of a photoactivatable taxol analogue to identify unique cellular targets in murine macrophages: identification of murine CD18 as a major taxol-binding protein and a role for Mac-1 in taxol-induced gene expression
N Bhat, P Y Perera, J M Carboni, et al.
Cancer Research
|
September 1, 1993
Transforming growth factor-beta 1 induces transforming growth factor-alpha promoter activity and transforming growth factor-alpha secretion in the human colon adenocarcinoma cell line FET
M J Lynch, L Pelosi, J M Carboni, et al.
Cancer Research
|
March 27, 1998
Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitaxel (Taxol)
B H Long, J M Carboni, A J Wasserman, et al.
Oncogene
|
May 18, 1995
Farnesyltransferase inhibitors are inhibitors of Ras but not R-Ras2/TC21, transformation
J M Carboni, N Yan, A D Cox, et al.
Oncogene
|
May 4, 1995
Bisubstrate inhibitors of farnesyltransferase: a novel class of specific inhibitors of ras transformed cells
V Manne, N Yan, J M Carboni, et al.
Journal of Medicinal Chemistry
|
February 3, 1995
Phosphinyl acid-based bisubstrate analog inhibitors of Ras farnesyl protein transferase
D V Patel, E M Gordon, R J Schmidt, et al.
Oncogene
|
August 2, 2011
A tripartite complex composed of ETV6-NTRK3, IRS1 and IGF1R is required for ETV6-NTRK3-mediated membrane localization and transformation
C E Tognon, M J Martin, A Moradian, et al.
Journal of Medicinal Chemistry
|
January 5, 1996
Development of highly potent inhibitors of Ras farnesyltransferase possessing cellular and in vivo activity
K Leftheris, T Kline, G D Vite, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
The Journal of Cell Biology
|
November 1, 1988
Structural and immunological characterization of the myosin-like 110-kD subunit of the intestinal microvillar 110K-calmodulin complex: evidence for discrete myosin head and calmodulin-binding domains
J M Carboni, K A Conzelman, R A Adams, et al.
The American Journal of Pathology
|
December 1, 1987
Characterization of intestinal brush border cytoskeletal proteins of normal and neoplastic human epithelial cells. A comparison with the avian brush border
J M Carboni, C L Howe, A B West, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 8, 1999
Use of a photoactivatable taxol analogue to identify unique cellular targets in murine macrophages: identification of murine CD18 as a major taxol-binding protein and a role for Mac-1 in taxol-induced gene expression
N Bhat, P Y Perera, J M Carboni, et al.
Cancer Research
|
September 1, 1993
Transforming growth factor-beta 1 induces transforming growth factor-alpha promoter activity and transforming growth factor-alpha secretion in the human colon adenocarcinoma cell line FET
M J Lynch, L Pelosi, J M Carboni, et al.
Cancer Research
|
March 27, 1998
Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitaxel (Taxol)
B H Long, J M Carboni, A J Wasserman, et al.
Oncogene
|
May 18, 1995
Farnesyltransferase inhibitors are inhibitors of Ras but not R-Ras2/TC21, transformation
J M Carboni, N Yan, A D Cox, et al.
Oncogene
|
May 4, 1995
Bisubstrate inhibitors of farnesyltransferase: a novel class of specific inhibitors of ras transformed cells
V Manne, N Yan, J M Carboni, et al.
Journal of Medicinal Chemistry
|
February 3, 1995
Phosphinyl acid-based bisubstrate analog inhibitors of Ras farnesyl protein transferase
D V Patel, E M Gordon, R J Schmidt, et al.
Oncogene
|
August 2, 2011
A tripartite complex composed of ETV6-NTRK3, IRS1 and IGF1R is required for ETV6-NTRK3-mediated membrane localization and transformation
C E Tognon, M J Martin, A Moradian, et al.
Journal of Medicinal Chemistry
|
January 5, 1996
Development of highly potent inhibitors of Ras farnesyltransferase possessing cellular and in vivo activity
K Leftheris, T Kline, G D Vite, et al.
Page
of 2